Protalix BioTherapeutics
PLX
#8947
Rank
NZ$0.37 B
Marketcap
NZ$4.60
Share price
-0.77%
Change (1 day)
10.27%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2026 (TTM): NZ$0.54

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is NZ$0.55. In 2025 the company made an earnings per share (EPS) of NZ-$0.14 a decrease over its 2024 EPS that were of NZ$0.07112.

EPS history for Protalix BioTherapeutics from 1996 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$0.54-479.27%
2025NZ-$0.14-300%
2024NZ$0.07112-66.67%
2023NZ$0.21-138.71%
2022NZ-$0.55-50%
2021NZ-$1.10181.82%
2020NZ-$0.39-82.11%
2019NZ-$2.19-31.67%
2018NZ-$3.20-72.31%
2017NZ-$11.56124.14%
2016NZ-$5.16-147.54%
2015NZ$10.85-290.63%
2014NZ-$5.696.67%
2013NZ-$5.33130.77%
2012NZ-$2.31-69.77%
2011NZ-$7.6419.44%
2010NZ-$6.40-12.2%
2009NZ-$7.2936.67%
2008NZ-$5.33-37.5%
2007NZ-$8.5350%
2006NZ-$5.693.23%
2005NZ-$5.51138.46%
2004NZ-$2.31-74%
2003NZ-$8.89-0%
2002NZ-$8.89-50%
2001NZ-$17.78233.33%
2000NZ-$5.33-84.21%
1999NZ-$33.78-24%
1998NZ-$44.45-600%
1997NZ$8.89-16.67%
1996NZ$10.67

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$1.35 145.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$12.53 2,174.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ-$0.20-135.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$1.12 103.23%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel